Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
33.61
+0.63 (1.91%)
At close: Mar 9, 2026, 4:00 PM EDT
33.80
+0.19 (0.57%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.88 billion as of March 9, 2026. Its market cap has increased by 10.19% in one year.
Market Cap
3.88B
Enterprise Value
3.18B
1-Year Change
10.19%
Ranking
Category
Stock Price
$33.61
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.88B, an increase of 4,911.33%. That is a compound annual growth rate of 43.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.81B | -4.16% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 4.32B |
| Structure Therapeutics | 4.09B |
| Ligand Pharmaceuticals | 4.03B |
| Crinetics Pharmaceuticals | 4.00B |
| Centessa Pharmaceuticals | 3.79B |
| ACADIA Pharmaceuticals | 3.78B |
| ADMA Biologics | 3.67B |
| Corcept Therapeutics | 3.60B |